RAMINTA MAKARAITE: Open Payments
NPI 1801513775 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 16 payments from 9 companies in 2025. Trend: 2023 $1,273 · 2024 $758 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $112 |
| PharmaEssentia USA Corporation | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Syndax Pharmaceuticals, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
Products named: BESREMI, TECVAYLI, TALVEY, LUTATHERA, INJECTAFER, ERLEADA, PEMAZYRE, GIVLAARI.
Industry payments across VA — which companies pay providers there.
